Tissue threshold changes during the first months of immunotherapy

Area of Science:

• Allergy and Immunology
• Immunotherapy Research
• Otorhinolaryngology

Background:

• Ragweed pollen is a common allergen causing allergic rhinitis and conjunctivitis.
• Immunotherapy aims to desensitize patients to allergens through controlled exposure.
• Assessing sensitivity changes during early immunotherapy is crucial for treatment monitoring.

Purpose of the Study:

• To evaluate changes in cutaneous, ocular, and nasal sensitivity to ragweed extract during early immunotherapy.
• To correlate these sensitivity changes with treatment dose and specific antibody levels.
• To investigate the relationship between tissue sensitivity thresholds and IgE levels.

Main Methods:

• Studied seven patients undergoing early-phase ragweed immunotherapy.
• Measured cutaneous, ocular, and nasal sensitivity to ragweed extract.
• Monitored cumulative extract dose, blocking antibody levels, and ragweed-specific IgE.

Main Results:

• Significant decrease in skin sensitivity (p < 0.01) observed.
• Reduced conjunctival and nasal sensitivity also noted.
• Sensitivity changes correlated with cumulative extract dose and blocking antibody levels.

Conclusions:

• Early ragweed immunotherapy effectively reduces allergic tissue sensitivity.
• Treatment efficacy correlates with dose and blocking antibodies.
• Ragweed-specific IgE levels did not correlate with observed tissue sensitivity changes.